Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
1 report, 1 independent
Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Analyst raised price objective for Elemental Altus Royalties stock.
- Analysts from Raymond James Financial, Desjardins, and Royal Bank of Canada increased price targets and ratings for Exchange Income Co.
- Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
- Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.
- Analyst upgraded rating and set price target for Pound Medical, and Royal Bank of Canada increased its share holdings.